These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25831801)

  • 1. [Skin disorders].
    Uhara H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():450-3. PubMed ID: 25831801
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin care for cancer patients.
    Lacouture ME
    Clin Adv Hematol Oncol; 2012 Nov; 10(11):748-50. PubMed ID: 23271263
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors.
    Balagula Y; Garbe C; Myskowski PL; Hauschild A; Rapoport BL; Boers-Doets CB; Lacouture ME
    Int J Dermatol; 2011 Feb; 50(2):129-46. PubMed ID: 21244375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and management of dermatologic toxicities associated with anti-EGFR therapy.
    Fox LP
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):26-34. PubMed ID: 16736980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin moisturization for xerosis related to targeted anticancer therapies.
    Gisondi P; Girolomoni G
    J Am Acad Dermatol; 2015 Jul; 73(1):e33. PubMed ID: 26089072
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to: "Skin moisturization for xerosis related to targeted anticancer therapies".
    Valentine J; Belum VR; Duran J; Ciccolini K; Schindler K; Wu S; Lacouture ME
    J Am Acad Dermatol; 2015 Jul; 73(1):e35-6. PubMed ID: 26089073
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of cutaneous adverse events induced by molecularly-targeted drugs].
    Nakahara T
    Fukuoka Igaku Zasshi; 2014 Sep; 105(9):175-81. PubMed ID: 25639024
    [No Abstract]   [Full Text] [Related]  

  • 8. [Managing cutaneous toxicities of targeted therapies].
    Kiyohara Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1597-602. PubMed ID: 23152009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial impact of cutaneous toxicities associated with epidermal growth factor receptor-inhibitor treatment.
    White KJ; Roydhouse JK; Scott K
    Clin J Oncol Nurs; 2011 Feb; 15(1):88-96. PubMed ID: 21278044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous reactions related to systemic immunomodulators and targeted therapeutics.
    Hammond-Thelin LA
    Dermatol Clin; 2008 Jan; 26(1):121-59, ix. PubMed ID: 18023775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted agents: management of dermatologic toxicities.
    Burtness B
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):793-6. PubMed ID: 24853219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-EGFR antibodies].
    Takahashi M
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():219-23. PubMed ID: 25831756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Skin toxicity, alopecia].
    Katsura Y; Akatsuka S; Toda Y; Arioka H
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():166-71. PubMed ID: 23156503
    [No Abstract]   [Full Text] [Related]  

  • 14. Side effects of targeted therapies: rash.
    Eaby-Sandy B; Lynch K
    Semin Oncol Nurs; 2014 Aug; 30(3):147-54. PubMed ID: 25085026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EGFR (epidermal growth factor receptor) inhibitor-associated skin disorders in tumor therapy].
    Reimer G; Brudler O; Heinrich B; Bangerter M
    MMW Fortschr Med; 2008 Dec; 150(49-50):37-8, 40. PubMed ID: 19133368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Skin damage by extravasation of chemotherapeutic agents].
    Yamamoto A
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():464-9. PubMed ID: 25831804
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker.
    Bianchini D; Jayanth A; Chua YJ; Cunningham D
    Clin Colorectal Cancer; 2008 Jan; 7(1):33-43. PubMed ID: 18279575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
    Tejwani A; Wu S; Jia Y; Agulnik M; Millender L; Lacouture ME
    Cancer; 2009 Mar; 115(6):1286-99. PubMed ID: 19170238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side effects of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)].
    Takeda K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():245-9. PubMed ID: 25831761
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous eruption related to human epidermal growth factor receptor inhibitors in stage IV colon cancer.
    Guzman L; Kozloff M; Wallace J; Starr A
    Clin J Oncol Nurs; 2009 Oct; 13(5):491-3. PubMed ID: 19793706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.